User contributions
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
- 08:57, 28 July 2021 (diff | hist) . . (0) . . m Breast cancer, ER-positive (current)
- 08:57, 28 July 2021 (diff | hist) . . (0) . . m Breast cancer - historical (current)
- 20:38, 27 July 2021 (diff | hist) . . (+15) . . m Breast cancer, triple negative (current)
- 20:37, 27 July 2021 (diff | hist) . . (+632) . . m Pembrolizumab (Keytruda) (→Triple-negative breast cancer (TNBC)) (current)
- 08:57, 27 July 2021 (diff | hist) . . (+36) . . m Non-small cell lung cancer (current)
- 08:42, 27 July 2021 (diff | hist) . . (+65) . . m Bladder cancer - null regimens (→Observation) (current)
- 08:34, 27 July 2021 (diff | hist) . . (+21) . . m Multiple myeloma - historical (current)
- 08:32, 27 July 2021 (diff | hist) . . (+12) . . m Chronic myelogenous leukemia (current)
- 08:10, 27 July 2021 (diff | hist) . . (-42) . . m Hodgkin lymphoma (current)
- 08:07, 27 July 2021 (diff | hist) . . (+78) . . m Colon cancer (current)
- 08:02, 27 July 2021 (diff | hist) . . (+13) . . m Gastrointestinal stromal tumor (→References) (current)
- 15:20, 26 July 2021 (diff | hist) . . (+12) . . m Melanoma - null regimens (current)
- 15:20, 26 July 2021 (diff | hist) . . (+12) . . m Melanoma (current)
- 15:14, 26 July 2021 (diff | hist) . . (-3) . . m Non-small cell lung cancer
- 09:49, 26 July 2021 (diff | hist) . . (+1) . . m Non-small cell lung cancer - historical (→References) (current)
- 21:54, 25 July 2021 (diff | hist) . . (+45) . . m Prostate cancer (→References) (current)
- 21:25, 25 July 2021 (diff | hist) . . (+3,680) . . m Non-small cell lung cancer
- 21:15, 25 July 2021 (diff | hist) . . (+1,362) . . m Non-small cell lung cancer (→Pembrolizumab monotherapy {{#subobject:430dc7|Regimen=1}})
- 16:51, 25 July 2021 (diff | hist) . . (+35) . . m Head and neck cancer - null regimens (→References) (current)
- 15:34, 25 July 2021 (diff | hist) . . (+2,015) . . N Ciltacabtagene autoleucel (JNJ-68284528) (Created page with "==Mechanism of action== From the [https://www.cancer.gov/publications/dictionaries/cancer-drug/def/ciltacabtagene-autoleucel NCI Drug Dictionary]: A preparation of autologous...") (current)
- 15:29, 25 July 2021 (diff | hist) . . (+46) . . m Drug index (→C) (current)
- 15:27, 25 July 2021 (diff | hist) . . (+817) . . m Nasopharyngeal carcinoma - null regimens (→Observation) (current)
- 15:26, 25 July 2021 (diff | hist) . . (+771) . . m Nasopharyngeal carcinoma (→Capecitabine monotherapy {{#subobject:5nz442|Regimen=1}}) (current)
- 19:44, 23 July 2021 (diff | hist) . . (+694) . . m Prostate cancer - null regimens (→References) (current)
- 19:42, 23 July 2021 (diff | hist) . . (+994) . . m Renal cell carcinoma (→Metastatic disease, third-line) (current)
- 18:29, 23 July 2021 (diff | hist) . . (+981) . . m Acute myeloid leukemia (→7+3d (intermediate-dose) {{#subobject:e82156|Regimen=1}}) (current)
- 12:50, 22 July 2021 (diff | hist) . . (+27) . . m Endometrial cancer (→Lenvatinib & Pembrolizumab {{#subobject:cffdf6|Regimen=1}}) (current)
- 12:49, 22 July 2021 (diff | hist) . . (-1) . . m Endometrial cancer (→Regimen variant #2, 8 cycles {{#subobject:5d91e9|Variant=1}})
- 12:49, 22 July 2021 (diff | hist) . . (-1) . . m Endometrial cancer (→Regimen variant #1, 80 mg/m2 {{#subobject:f1676a|Variant=1}})
- 12:48, 22 July 2021 (diff | hist) . . (+1,665) . . m Endometrial cancer (→Non-endocrine therapy for advanced, recurrent, or metastatic disease)
- 08:41, 22 July 2021 (diff | hist) . . (+33) . . m Endometrial cancer (→References)
- 08:40, 22 July 2021 (diff | hist) . . (+353) . . m Pembrolizumab (Keytruda) (→Endometrial cancer)
- 21:48, 21 July 2021 (diff | hist) . . (-3) . . m Colon cancer, RAS wild-type (current)
- 12:24, 21 July 2021 (diff | hist) . . (-3) . . m Esophageal adenocarcinoma (current)
- 12:21, 21 July 2021 (diff | hist) . . (-6) . . m B-cell acute lymphoblastic leukemia - historical (current)
- 09:26, 21 July 2021 (diff | hist) . . (+12) . . m Acute myeloid leukemia
- 09:17, 19 July 2021 (diff | hist) . . (-9) . . m Colon cancer
- 07:37, 19 July 2021 (diff | hist) . . (-3) . . m Breast cancer, ER-positive (→References)
- 21:53, 18 July 2021 (diff | hist) . . (+12) . . m Prostate cancer
- 21:49, 18 July 2021 (diff | hist) . . (+12) . . m Prostate cancer
- 21:41, 18 July 2021 (diff | hist) . . (0) . . m Head and neck cancer (current)
- 21:36, 18 July 2021 (diff | hist) . . (+12) . . m Breast cancer, triple negative
- 21:32, 18 July 2021 (diff | hist) . . (+12) . . m Rectal cancer (→References) (current)
- 21:01, 18 July 2021 (diff | hist) . . (+26) . . m Breast cancer (current)
- 19:28, 18 July 2021 (diff | hist) . . (+55) . . m Small cell lung cancer (current)
- 19:24, 18 July 2021 (diff | hist) . . (+12) . . m Breast cancer (→References)
- 17:55, 18 July 2021 (diff | hist) . . (+55) . . m Non-small cell lung cancer
- 17:47, 18 July 2021 (diff | hist) . . (+12) . . m Rectal cancer
- 17:46, 18 July 2021 (diff | hist) . . (+24) . . m Breast cancer
- 16:33, 18 July 2021 (diff | hist) . . (-191) . . m Breast cancer, HER2-positive (→FEC {{#subobject:3613b7|Regimen=1}}) (current)
(newest | oldest) View (newer 50 | older 50) (20 | 50 | 100 | 250 | 500)
